Results 41 to 50 of about 37,917 (298)

Drug resistance with monitored adherence [PDF]

, 2013
Drug resistance can be defined as the failure of a drug to exert its expected effect on pharmacological biomarkers and is caused by pharmacogenetic, cellular or clinical factors.
Walter, Philipp Niklaus
core   +1 more source

Ultra-Early Combination Antiplatelet Therapy with Cilostazol for the Prevention of Branch Atheromatous Disease: A Multicenter Prospective Study

Cerebrovascular Diseases Extra, 2016
Background and Purpose: The optimal use of antiplatelet therapy for intracranial branch atheromatous disease (BAD) is not known. Methods: We conducted a prospective multicenter, single-group trial of 144 consecutive patients diagnosed with probable BAD ...
Teruo Kimura, Adam Tucker, Toshihide Sugimura, Toshitaka Seki, Shin Fukuda, Satoru Takeuchi, Shiro Miyata, Tsutomu Fujita, Akira Hashizume, Naoto Izumi, Kazutsune Kawasaki, Makoto Katsuno, Masaaki Hashimoto, Kazuhiro Sako   +13 more
doaj   +1 more source

Vorapaxar as an Alternative for Ticagrelor Resistance in Neuroendovascular Intervention

Stroke: Vascular and Interventional Neurology, 2021
Background Perioperative dual‐antiplatelet therapy for flow diversion limits thromboembolic complications. However, resistance to dual‐antiplatelet therapy medications remains a concern for neuroendovascular intervention.
James C. Mamaril‐Davis, Pedro Aguilar‐Salinas, Leonardo B. Brasiliense, Richard Cosgrove, Judy Dawod, Travis M. Dumont, Mohammad El‐Ghanem   +6 more
doaj   +1 more source

Ticagrelor Alone or Conventional Dual Antiplatelet Therapy in Patients With Stable or Acute Coronary Syndromes [PDF]

, 2020
To investigate the effect of ticagrelor monotherapy after 1-month dual antiplatelet therapy (DAPT) or conventional DAPT in patients with or without acute coronary syndrome (ACS) in the GLOBAL LEADERS Adjudication Sub-Study (GLASSY)
Christian Hamm, Anna Franzone, Jüni, Peter, Eugène P. McFadden, Hamm, Christian, Leonardi, Sergio, Mattia Branca, Steg, Philippe Gabriel, McFadden, Eugène P, Vranckx, Pascal, Sergio Leonardi, Heg, Dik, Windecker, Stephan, Pascal Vranckx, Philippe Gabriel Steg, Branca, Mattia, Piccolo, Raffaele, Marco Valgimigli., McFadden, Eugène P., Stephan Windecker, Franzone, Anna, Patrick W Serruys, Dik Heg, Peter Jüni, Serruys, Patrick W., Raffaele Piccolo, Serruys, Patrick W, Valgimigli, Marco   +27 more
core   +1 more source

Bleeding complications related to external ventricular drainage placement in patients with ruptured intracranial aneurysms: a single-center study

Frontiers in Surgery
ObjectiveAcute aneurysmal rupture can be treated with endovascular therapy or surgical clipping. For patients with concurrent acute hydrocephalus, the placement of an external ventricular drainage (EVD) is required.
Yue Tang, Xiangping Zhong, Tingting Lin, Fujun Zuo, Min Fu, Li Wang, Xiaodu Yu, Dong Liu, Jincan Zhang   +8 more
doaj   +1 more source

2021 Asian Pacific Society of Cardiology Consensus Recommendations on the Use of P2Y12 Receptor Antagonists in the Asia-Pacific Region: Special Populations

European Cardiology Review, 2021
Advanced age, diabetes, and chronic kidney disease not only increase the risk for ischaemic events in chronic coronary syndromes (CCS) but also confer a high bleeding risk during antiplatelet therapy. These special populations may warrant modification of
Jack Wei Chieh Tan, Derek P Chew, Kin Lam Tsui, Doreen Tan, Dmitry Duplyakov, Ayman Hammoudeh, Bo Zhang, Yi Li, Kai Xu, Paul J Ong, Doni Firman, Habib Gamra, Wael Almahmeed, Jamshed Dalal, Li-Wah Tam, Gabriel Steg, Quang N Nguyen, Junya Ako, Jassim Al Suwaidi, Mark Chan, Mohamed Sobhy, Abdulla Shehab, Wacin Buddhari, Zulu Wang, Alan Yean Yip Fong, Bilgehan Karadag, Byeong-Keuk Kim, Usman Baber, Chee Tang Chin, Ya Ling Han   +29 more
doaj   +1 more source

Optimal Duration of Dual Antiplatelet Therapy after Stent- Assisted Coil Embolization of Unruptured Intracranial Aneurysms : A Prospective Randomized Multicenter Trial [PDF]

, 2022
OBJECTIVE: Stent-assisted coil embolization (SAC) has been increasingly used to treat various types of intracranial aneurysms. Delayed thromboembolic complications are major concerns regarding this procedure, so dual antiplatelet therapy with aspirin and
Kim, Chang-Hyun, Hyon-Jo Kwon, Young Deok Kim, Keun Young Park, Ban, Seung Pil, Kim, YD, Jae Sang Oh, Park, Jung Cheol, Kim, Young Woo, Kwon, Hyon-Jo, Jung Cheol Park, Oh, JS, Seung Pil Ban, Kang Min Kim, Yong Cheol Lim, Sukh Que Park, Chang Hyeun Kim, Park, JC, Park, Sukh Que, Choi, Jai Ho, Kwon, OK, Kim, KM, Chung, J, Oh, Jae Sang, Kwon, O-Ki, Kim, CH, Byoun, HS, Kim, BT, Ban, SP, Park, Keun Young, Lim, Yong Cheol, Park, SQ, Kim, Chang Hyeun, Kim, Young Deok, Kim, Kang Min, Kim, Bum-Tae, Hyoung Soo Byoun, Kwon, HJ, Chang-Hyun Kim, Chung, Joonho, Choi, JH, Lim, YC, Young Woo Kim, Kim, YW, O-Ki Kwon, Park, KY, Joonho Chung, Bum-Tae Kim, Byoun, Hyoung Soo, Jai Ho Choi   +49 more
core   +3 more sources

Cardiopulmonary resuscitation with assisted extracorporeal life support during cardiac arrest caused by drug-eluting stent thrombosis: a case report [PDF]

Korean Journal of Anesthesiology, 2014
Discontinuation of dual antiplatelet therapy within 12 months after drug-eluting stent (DES) implantation increases the possibility of stent thrombosis.
Ju-Hyun Lee, Sang-Heon Park, In Ae Song
doaj   +1 more source

Long Term Cardiovascular Outcome Based on Aspirin and Clopidogrel Responsiveness Status in Young ST-Elevated Myocardial Infarction Patients

Arquivos Brasileiros de Cardiologia, 2018
Background: A subset of patients who take antiplatelet therapy continues to have recurrent cardiovascular events which may be due to antiplatelet resistance.
Mustafa Umut Somuncu, Ali Riza Demir, Seda Tukenmez Karakurt, Huseyin Karakurt, Turgut Karabag   +4 more
doaj   +1 more source

TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy Versus Ticagrelor Plus Aspirin Beginning at 3 Months in High-risk Patients Undergoing Percutaneous Coronary Intervention

US Cardiology Review, 2020
A P2Y12 inhibitor-based monotherapy after a short period of dual antiplatelet therapy is emerging as a plausible strategy to decrease bleeding events in high-risk patients receiving dual antiplatelet therapy after percutaneous coronary intervention ...
Johny Nicolas, Usman Baber, Roxana Mehran   +2 more
doaj   +1 more source